Lion Point Capital »

Spruce Biosciences shares owned by Lion Point Capital

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $39k 75k 0.52
2024-03-31 $59k 75k 0.79

More positions owned by Lion Point Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Ardelyx (ARDX)
Insmed Com Par $.01 (INSM)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Milestone Pharmaceuticals (MIST)
Geron Corporation (GERN)
Marinus Pharmaceuticals Com New (MRNS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Mirum Pharmaceuticals Put Option (MIRM)
Syndax Pharmaceuticals (SNDX)
Bridgebio Pharma (BBIO)
Avadel Pharmaceuticals Com Shs (AVDL)
Neurocrine Biosciences (NBIX)
Fennec Pharmaceuticals (FENC)
Mineralys Therapeutics (MLYS)

View all positions for Lion Point Capital

Top funds holding Spruce Biosciences

RiverVest Venture Management
Carlyle
Rock Springs Capital Management
Acadian Asset Management
Vanguard Group
Altium Capital Management
Almitas Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
683 Capital Management
BlackRock
Bridgeway Capital Management
Superstring Capital Management
Lion Point Capital

View all funds holding Spruce Biosciences